Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open, Multi-Center, Controlled Study to Evaluate the Safety, Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation

NCT03477734 is registered in ClinicalTrials.gov with CardiacSense Ltd. as lead sponsor.

NCT NCT03477734
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477734 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open, Multi-Center, Controlled Study to Evaluate the Safety, Performance and Efficacy of the CardiacSense1 for Detection of Atrial Fibrillation
Lead sponsor
CardiacSense Ltd.
Phase
Not applicable
Overall status
Completed
Start date
February 20, 2019
Completion date
June 9, 2020
Enrollment
53 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrium; fibrillation